An expert discusses how the treatment landscape for lower-risk MDS has evolved with multiple new options including luspatercept, imetelstat, and lenalidomide based on specific patient characteristics ...

Researchers are developing AI programmes to make doping detection more effective, faster, and cheaper. How do these systems ...

The global erythropoietin drugs market was valued at approximately USD 6.87 billion in 2022 and is projected to grow at a healthy growth rate of around 1.5% during the forecast period from 2023 to ...

Two positives, two sporting careers abruptly halted due to the use of prohibited substances, and two sanctions for crossing the red line. The ...

Mean age was 8.86 years, and 51.2% were male. The cohort’s mean erythropoietin resistance index (ERI; weekly EPO dose per kg body weight per mean hemoglobin) was 28.87.

Erythropoietin (EPO), a glycoprotein hormone, is a fundamental regulator of erythropoiesis. The expression of EPO is tightly regulated by local changes in the partial pressure of oxygen.

In contrast, 40% of mice with macrophages unable to make the EPO receptor lived for 18 weeks after tumor induction, when the experiment was terminated. When anti-PD-1 treatment was given to mice ...

Stanford University scientists have found that erythropoietin (EPO), a protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells also plays a surprising ...

Erythropoietin — also known as EPO — is mostly remembered as the drug that cyclist Lance Armstrong dishonestly used to win seven Tours de France. The blood thickener’s role in a cancer drug ...

Erythropoietin (EPO) is a 30.4 kDa glycoprotein comprised of one 165 amino acid residues chain with four glycosylation locations (Figure 1). The hormone is produced naturally in the kidneys ...